Transgender persons can face a number of barriers in accessing primary and specialist care that is equitable, inclusive and appropriate for their needs. In this Viewpoint, commissioned to recognize Pride, five researchers with expertise across different disciplines, including nephrology, endocrinology, public health, psychology and sociology, provide their perspectives on key considerations that are required to achieve optimal primary and nephrology care for transgender individuals, including barriers to care and how these might be overcome to ensure that the provision of care is inclusive and safe.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Krupka, E. et al. The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 17, 1305–1315 (2022).
Eckenrode, H. E., Gutierrez, O. M., Osis, G., Agarwal, A. & Curtis, L. M. Kidney disease prevalence in transgender individuals. Clin. J. Am. Soc. Nephrol. 17, 280–282 (2022).
Ashley, F. ‘Trans’ is my gender modality: a modest terminological proposal. in Trans Bodies, Trans Selves 2nd edn, Vol. 22 (ed Erickson-Schroth, L.) (Oxford University Press, 2021).
Felt, D. et al. Instability in housing and medical care access: the inequitable impacts of the COVID-19 pandemic on U.S. transgender populations. Transgend. Health 8, 74–83 (2023).
Rytz, C. L. et al. Improving the inclusion of transgender and nonbinary individuals in the planning, completion, and mobilization of cardiovascular research. Am. J. Physiol. Heart Circ. Physiol. 324, H366–H372 (2023).
Streed, C. G. Jr et al. Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association. Circulation 144, e136–e148 (2021).
Lee, K. et al. Heart-kidney transplantation in a transgender woman. JACC Case Rep. 4, 101523 (2022).
Whitley, C. T. & Greene, D. N. Transgender man being evaluated for a kidney transplant. Clin. Chem. 63, 1680–1683 (2017).
Treharne, G. J., Carroll, R., Tan, K. K. H. & Veale, J. F. Supportive interactions with primary care doctors are associated with better mental health among transgender people: results of a nationwide survey in Aotearoa/New Zealand. Fam. Pract. 39, 834–842 (2022).
Greene, D. N., Dy, G. W., Osbun, N. & Whitley, C. T. Reply to “Kidney transplantation and donation in the transgender population: a single-institution case series”. Am. J. Transplant. 20(12), 3693–3694 (2020).
Caughey, A. B. et al. USPSTF approach to addressing sex and gender when making recommendations for clinical preventive services. JAMA 326, 1953–1961 (2021).
Tan, K. K. H., Carroll, R., Treharne, G. J., Byrne, J. L. & Veale, J. F. ‘I teach them. I have no choice’: experiences of primary care among transgender people in Aotearoa New Zealand. N. Z. Med. J. 135, 59–72 (2022).
American Medical Association https://www.ama-assn.org/press-center/press-releases/ama-reinforces-opposition-restrictions-transgender-medical-care (2021).
Rafferty et al. Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents. Pediatrics 142, e20182162 (2018).
Grasso, C. et al. Optimizing gender-affirming medical care through anatomical inventories, clinical decision support, and population health management in electronic health record systems. J. Am. Med. Inf. Assoc. 28, 2531–2535 (2021).
Mohottige, D. & Lunn, M. R. Ensuring gender-affirming care in nephrology: Improving care for transgender and gender-expansive individuals. Clin. J. Am. Soc. Nephrol. 15, 1195–1197 (2020).
Adams, N. et al. Guidance and ethical considerations for undertaking transgender health research and institutional review boards adjudicating this research. Transgend. Health 2, 165–175 (2017).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
The contributors
Sofia B. Ahmed is a Professor of Medicine at the University of Calgary. She is a nephrologist with a focus on sex and gender differences in kidney and cardiovascular outcomes, Advisory Board member for the Canadian Institutes of Health Research Institute of Gender and Health and the President-Elect for the Organization for the Study of Sex Differences.
Lauren B. Beach is Assistant Professor in the Northwestern Department of Medical Social Sciences and Department of Preventive Medicine, Director of the ReACH SGM lab (Research on Aging, Chronic Conditions, and Health Equity in Sexual and Gender Minority populations), and Director of the ADVOCATE SGM Health program within the Institute for Sexual and Gender Minority Health and Wellbeing. Scientifically, Lauren Beach investigates the epidemiology of aging and chronic physical health conditions among diverse sexual and gender minority (SGM) populations and people with HIV. They also study how multilevel health- and identity-related stigmas affect health care quality, chronic condition management and health outcomes of minoritized populations.
Joshua Safer is the Executive Director of the Mount Sinai Center for Transgender Medicine and Surgery in New York City and Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is a co-author of the Endocrine Society guidelines for the medical care of transgender patients, the World Professional Association for Transgender Health (WPATH) standards of care (version 8), and the gender-affirming hormone treatment sections for UpToDate. He was the inaugural president of the United States Professional Association for Transgender Health, is a WPATH board member, serves on the Global Education Institute for WPATH and has been a scientific co-chair for multiple WPATH international meetings.
Jaimie Veale (she/her) is a Rutherford Discovery Fellow and Senior Lecturer in Psychology at the University of Waikato, Aotearoa, New Zealand. She is President of the Professional Association for Transgender Health Aotearoa (PATHA) and Secretary of the World Professional Association for Transgender Health (WPATH). She is a co-author of the WPATH Standards of Care, version 8.
Cameron T. Whitley (he/they) is an Associate Professor in the Department of Sociology at Western Washington University. He studies issues concerning the environment, human–animal relationships and transgender-affirming medicine. He has over four dozen publications in journals such as Proceedings of the National Academy of Sciences, Academic Emergency Medicine and Clinical Chemistry. In answering these questions, he has a unique perspective as a transgender-identified researcher and a kidney transplant recipient.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ahmed, S.B., Beach, L.B., Safer, J.D. et al. Considerations in the care of transgender persons. Nat Rev Nephrol 19, 360–365 (2023). https://doi.org/10.1038/s41581-023-00713-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-023-00713-0